Abstract
Microchimerism has been defined by the presence of a low number of circulating cells transferred from one individual to another. This transfer takes place naturally during pregnancy, between mother and fetus and / or between fetuses in multi-gestational pregnancies. Furthermore, the establishment of microchimerism can also occur during blood transfusion and organ transplants. Microchimeric cells have been implicated in health and disease. Microchimerism has been correlated with the hyporesponsiveness of the maternal immune system towards the fetal allograft and with the longevity of organ transplants. However, maternal microchimeric cells have been implicated in diseases of the neonate including neonatal graft-versus-host disease, severe combined immunodeficiency and erythema toxicum neonatorum. And more recently, microchimeric cells have been implicated in the pathogenesis of autoimmune diseases including systemic sclerosis and myositis.
Keywords: microchimerism, disease, circulating cells, multi-gestational pregnancies, organ transplants, graft-versus-host, autoimmune diseases, myositis
Current Molecular Medicine
Title: Microchimerism in Health and Disease
Volume: 2 Issue: 6
Author(s): Carol M. Artlett
Affiliation:
Keywords: microchimerism, disease, circulating cells, multi-gestational pregnancies, organ transplants, graft-versus-host, autoimmune diseases, myositis
Abstract: Microchimerism has been defined by the presence of a low number of circulating cells transferred from one individual to another. This transfer takes place naturally during pregnancy, between mother and fetus and / or between fetuses in multi-gestational pregnancies. Furthermore, the establishment of microchimerism can also occur during blood transfusion and organ transplants. Microchimeric cells have been implicated in health and disease. Microchimerism has been correlated with the hyporesponsiveness of the maternal immune system towards the fetal allograft and with the longevity of organ transplants. However, maternal microchimeric cells have been implicated in diseases of the neonate including neonatal graft-versus-host disease, severe combined immunodeficiency and erythema toxicum neonatorum. And more recently, microchimeric cells have been implicated in the pathogenesis of autoimmune diseases including systemic sclerosis and myositis.
Export Options
About this article
Cite this article as:
Artlett M. Carol, Microchimerism in Health and Disease, Current Molecular Medicine 2002; 2 (6) . https://dx.doi.org/10.2174/1566524023362131
DOI https://dx.doi.org/10.2174/1566524023362131 |
Print ISSN 1566-5240 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5666 |
![](/images/wayfinder.jpg)
- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Pharmacological Regulation of Dyslipoproteinaemia in Insulin Resistant States
Current Vascular Pharmacology Dichotomous Life of DNA Binding High Mobility Group Box1 Protein in Human Health and Disease
Current Protein & Peptide Science PCSK9 and LDLR The Yin-Yang in the Cellular Uptake of Cholesterol
Current Hypertension Reviews Autoantibodies Among HIV-1 Infected Individuals and the Effect of Anti-Retroviral Therapy (ART) on It
Current HIV Research Targeting Serine Proteases in Asthma
Current Topics in Medicinal Chemistry Patent Selections :
Recent Patents on Cardiovascular Drug Discovery Statins: Are They All the Same?
Current Drug Therapy Update on Myositis Therapy: From Today’s Standards to Tomorrow’s Possibilities
Current Pharmaceutical Design Cholesterol Absorption Blockade with Ezetimibe
Current Drug Targets - Cardiovascular & Hematological Disorders Editorial (Thematic Issue: Biologics in Autoimmune Diseases)
Current Pharmaceutical Biotechnology Lipid-lowering Drug Therapy in Elderly Patients
Current Pharmaceutical Design Pharmacogenetics of Statins Therapy
Recent Patents on Cardiovascular Drug Discovery Pulmonary Infections in the Era of Biological Agents
Current Respiratory Medicine Reviews Protein Misfolding in Disease: Cause or Response?
Current Medicinal Chemistry - Immunology, Endocrine & Metabolic Agents Chemokines in Rheumatic Diseases
Current Drug Targets Diffuse Alveolar Hemorrhage, A Potentially Life-Threatening Manifestation in Systemic Lupus Erythematosus and the Antiphospholipid Syndrome
Current Respiratory Medicine Reviews Prevalence of <i>Toxoplasma gondii</i> and <i>Toxocara canis</i> Among Myositis Patients in the Southwest of Iran
Infectious Disorders - Drug Targets The Host Complement System and Arbovirus Pathogenesis
Current Drug Targets Small Heat Shock Proteins and Protein-Misfolding Diseases
Current Pharmaceutical Biotechnology Systemic Lupus Erythematosus-Related Interstitial Lung Disease
Current Rheumatology Reviews